Altman Clinical and Translational Research Institute
La Jolla, California, 92093, United States
NCT Number: NCT05014880
The purpose of this study is to see if reducing the number of hours during which one eats each day will help reduce levels of LDL cholesterol and improve other markers of metabolic and cardiovascular health (i.e. blood sugar levels and blood pressure). The study also aims to assess changes in exercise capacity and trimethylamine N-oxide (TMAO) levels in response to Time Restricted Eating (TRE) and Intensive Cardiac Rehabilitation (ICR) versus ICR alone. TMAO is a metabolite, or a substance, produced during digestion and metabolism. Preliminary data illustrates a correlation between high levels of TMAO and higher risk of cardiovascular disease and mortality. We will also be looking at participants' long-term cardiovascular health status after they complete the ICR program.
This study is active but is not currently recruiting participants.
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
La Jolla, California, 92093, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in this arm will not have to adopt a 10-hour eating window while taking part in UCSD's 9-week ICR program.
Participants in this arm will adhere to a daily, consistent 10-hour eating window while undergoing UCSD's 9-week ICR program to see if there is an improvement on cardiometabolic parameters.
Time frame: Baseline and Week 1-9
Exercise Capacity
Time frame: Baseline and Week 9
LDL cholesterol (mg/dL)
Time frame: Baseline and Week 9
non-HDL cholesterol (mg/dL)
Time frame: Baseline and Week 9
Triglycerides (mg/dL)
Time frame: Baseline and Week 9
TMAO levels (uM)
University of California, San Diego
Other
Impact of Time Restricted Eating on Exercise Capacity, Cardiometabolic Parameters, and Trimethylamine N-oxide (TMAO) Levels in Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation
Acronym: TRE x ICR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05075317
Arterial Occlusive Diseases, Arteriosclerosis
Toronto, Ontario, Canada
View Trial DetailsNCT05755711
Arterial Occlusive Diseases, Arteriosclerosis
Loma Linda, California, United States
View Trial DetailsNCT06885177
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT04763200
Anterior Wall Myocardial Infarction, Arterial Occlusive Diseases
Birmingham, Alabama, United States
View Trial Details